{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,4,19]],"date-time":"2023-04-19T14:21:23Z","timestamp":1681914083600},"reference-count":135,"publisher":"Bentham Science Publishers Ltd.","issue":"5","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CDT"],"published-print":{"date-parts":[[2021,4]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>Hepatitis C Virus (HCV) belongs to the Hepacivirus family. HCV has been\ndesignated as a very dreadful virus as it can attack the liver, causing inflammation and even may lead\nto cancer in chronic conditions. It was estimated that 71 million people around the world have chronic\nHCV infection. World Health Organization (WHO) reported that about 399000 people died because of\nchronic cirrhosis and liver cancer globally. In spite of the abundance of availability of drugs for the\ntreatment of HCV, however, the issue of drug resistance surpasses all the possibilities of therapeutic\nmanagement of HCV. Therefore, to address this issue of \u2018drug-resistance\u2019, various HCV targets were\nexplored to quest the evaluation of the mechanism of the disease progression.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>An attempt has been made in the present study to explore the various targets of HCV involved\nin the mechanism(s) of the disease initiation and progression and to focus on the mode of binding\nof ligands, which are co-crystallized at the active cavity of different HCV targets.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p> The present study could predict some crucial features of these ligands, which possibly\ninteracted with various amino acid residues responsible for their biological activity and molecular signaling\npathway(s). Such binding mode may be considered as a template for the high throughput\nscreening and designing of active congeneric ligands to combat HCV.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1389450121999200727215020","type":"journal-article","created":{"date-parts":[[2020,7,28]],"date-time":"2020-07-28T09:01:42Z","timestamp":1595926902000},"page":"590-604","update-policy":"http:\/\/dx.doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["To Explore the Potential Targets and Current Structure-based Design Strategies Utilizing Co-crystallized Ligand to Combat HCV"],"prefix":"10.2174","volume":"22","author":[{"given":"Heena","family":"Tarannum","sequence":"first","affiliation":[{"name":"Department of Pharmaceutical Chemistry, Global Institute of Pharmaceutical Education and Research (Affiliated to Uttarakhand Technical University), Kashipur-244713,India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bhumika","family":"Chauhan","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Chemistry, Global Institute of Pharmaceutical Education and Research (Affiliated to Uttarakhand Technical University), Kashipur-244713,India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asmita","family":"Samadder","sequence":"additional","affiliation":[{"name":"Cytogenetics and Molecular Biology Lab., Department of Zoology, University of Kalyani, Kalyani, Nadia, 741235,India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harekrishna","family":"Roy","sequence":"additional","affiliation":[{"name":"Nirmala College of Pharmacy, Mangalagiri, Guntur, Andhra Pradesh, 522503,India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sisir","family":"Nandi","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Chemistry, Global Institute of Pharmaceutical Education and Research (Affiliated to Uttarakhand Technical University), Kashipur-244713,India"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","DOI":"10.5005\/jp\/books\/11091","author":"Mohan H.","unstructured":"Mohan H.;  Textbook of pathology6th ed published by Jaypee brother\u2019s medical publisher\u2019s pvtltd 2010","journal-title":"Textbook of pathology6th ed published by Jaypee brother\u2019s medical publisher\u2019s pvtltd 2010"},{"key":"ref=2","year":"2019","unstructured":"World health organization [WHO] 2019","journal-title":"World health organization [WHO]"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.canlet.2013.06.028","volume":"345","author":"Rusyn I.","year":"2014","unstructured":"Rusyn I.; Lemon S.M.; Mechanisms of HCV-induced liver cancer: what did we learn from in vitro and animal studies? Cancer Lett 2014,345(2),210-215","journal-title":"Cancer Lett"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"327","DOI":"10.4254\/wjh.v7.i3.327","volume":"7","author":"Ferri C.","year":"2015","unstructured":"Ferri C.; Sebastiani.; Giuggioli, D.; Colaci, M.; Fallahi, P.; Piluso, A.; Antonelli, A.; Zignego, A.N. HCV syndrome: A constellation of organ- and non-organ specific autoimmune disorders, B-cell non-Hodgkin\u2019s lymphoma, and cancer. World J Hepatol 2015,7(3),327-343","journal-title":"World J Hepatol"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1016\/j.jhep.2014.06.031","volume":"61","author":"Dubuisson J.","year":"2014","unstructured":"Dubuisson J.; Cosset F.L.; Virology and cell biology of the hepatitis C virus life cycle: an update. J Hepatol 2014,61(1)(Suppl.),S3-S13","journal-title":"J Hepatol"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s00795-006-0317-8","volume":"39","author":"Kaito M.","year":"2006","unstructured":"Kaito M.; Ishida S.; Tanaka H.; Morphology of hepatitis C and hepatitis B virus particles as detected by immunogold electron microscopy. Med Mol Morphol 2006,39(2),63-71","journal-title":"Med Mol Morphol"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1002\/rmv.391","volume":"13","author":"Op De Beeck A.","year":"2003","unstructured":"Op De Beeck A.; Dubuisson J.; Topology of hepatitis C virus envelope glycoproteins. Rev Med Virol 2003,13(4),233-241","journal-title":"Rev Med Virol"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1038\/s41598-017-00320-7","volume":"7","author":"Castelli M.","year":"2017","unstructured":"Castelli M.; Clementi N.; Pfaff J.; A Biologically-validated HCV E1E2 Heterodimer Structural Model. Sci Rep 2017,7(1),214","journal-title":"Sci Rep"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"4478","DOI":"10.1128\/JVI.78.9.4478-4486.2004","volume":"78","author":"Basu A.","year":"2004","unstructured":"Basu A.; Beyene A.; Meyer K.; Ray R.; The hypervariable region 1 of the E2 glycoprotein of hepatitis C virus binds to glycosaminoglycans, but this binding does not lead to infection in a pseudotype system. J Virol 2004,78(9),4478-4486","journal-title":"J Virol"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1089\/omi.1.2000.5.129","volume":"5","author":"Kato N.","year":"2000","unstructured":"Kato N.; Genome of human hepatitis C virus (HCV): gene organization, sequence diversity, and variation. Microb Comp Genomics 2000,5(3),129-151","journal-title":"Microb Comp Genomics"},{"key":"ref=11","first-page":"278","volume":"3","author":"Jubin R.","year":"2001","unstructured":"Jubin R.; Hepatitis C IRES: translating translation into a therapeutic target. Curr Opin Mol Ther 2001,3(3),278-287","journal-title":"Curr Opin Mol Ther"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1016\/j.str.2011.08.002","volume":"19","author":"Berry K.E.","year":"2011","unstructured":"Berry K.E.; Waghray S.; Mortimer S.A.; Bai Y.; Doudna J.A.; Crystal structure of the HCV IRES central domain reveals strategy for start-codon positioning. Structure 2011,19(10),1456-1466","journal-title":"Structure"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"2406","DOI":"10.3748\/wjg.v13.i17.2406","volume":"13","author":"Dubuisson J.","year":"2007","unstructured":"Dubuisson J.; Hepatitis C virus proteins. World J Gastroenterol 2007,13(17),2406-2415","journal-title":"World J Gastroenterol"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-3-642-27340-7_1","volume":"369","author":"Simmonds P.","year":"2013","unstructured":"Simmonds P.; The origin of hepatitis C virus. Curr Top Microbiol Immunol 2013,369,1-15","journal-title":"Curr Top Microbiol Immunol"},{"key":"ref=15","doi-asserted-by":"crossref","first-page":"473","DOI":"10.20506\/rst.34.2.2372","volume":"34","author":"Choumet V.","year":"2015","unstructured":"Choumet V.; Despres Ph.; Dengue and other flavivirus infections. Rev Sci Tech 2015,34(2),473-478","journal-title":"Rev Sci Tech"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"811","DOI":"10.2174\/1389450116666150806123119","volume":"18","author":"Maggi F.","year":"2017","unstructured":"Maggi F.; Focosi D.; Pistello M.; How current direct-acting antiviral and novel cell culture systems for HCV are shaping therapy and molecular diagnosis of chronic HCV infection. Curr Drug Targets 2017,18(7),811-825","journal-title":"Curr Drug Targets"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.chom.2014.10.008","volume":"16","author":"Paul D.","year":"2014","unstructured":"Paul D.; Madan V.; Bartenschlager R.; Hepatitis C virus RNA replication and assembly: living on the fat of the land. Cell Host Microbe 2014,16(5),569-579","journal-title":"Cell Host Microbe"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"6919","DOI":"10.1128\/JVI.76.14.6919-6928.2002","volume":"76","author":"Andr&#xE9; P.","year":"2002","unstructured":"Andr&#xE9; P.; Komurian-Pradel F.; Deforges S.; Characterization of low- and very-low-density hepatitis C virus RNA-containing particles. J Virol 2002,76(14),6919-6928","journal-title":"J Virol"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/978-3-642-27340-7_7","volume":"369","author":"Lohmann V.","year":"2013","unstructured":"Lohmann V.; Hepatitis C virus RNA replication. Curr Top Microbiol Immunol 2013,369,167-198","journal-title":"Curr Top Microbiol Immunol"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/978-3-642-27340-7_6","volume":"369","author":"Niepmann M.","year":"2013","unstructured":"Niepmann M.; Hepatitis C virus RNA translation. Curr Top Microbiol Immunol 2013,369,143-166","journal-title":"Curr Top Microbiol Immunol"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.antiviral.2014.02.013","volume":"105","author":"Ball J.K.","year":"2014","unstructured":"Ball J.K.; Tarr A.W.; McKeating J.A.; The past, present and future of neutralizing antibodies for hepatitis C virus. Antiviral Res 2014,105,100-111","journal-title":"Antiviral Res"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1002\/hep.21959","volume":"47","author":"Timpe J.M.","year":"2008","unstructured":"Timpe J.M.; Stamataki Z.; Jennings A.; Hepatitis C virus cell-cell transmission in hepatoma cells in the presence of neutralizing antibodies. Hepatology 2008,47(1),17-24","journal-title":"Hepatology"},{"key":"ref=23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1004128","volume":"10","author":"Xiao F.","year":"2014","unstructured":"Xiao F.; Fofana I.; Heydmann L.; Hepatitis C virus cell-cell transmission and resistance to direct-acting antiviral agents. PLoS Pathog 2014,10(5)","journal-title":"PLoS Pathog"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"12557","DOI":"10.1128\/JVI.00838-11","volume":"85","author":"Yoon J.C.","year":"2011","unstructured":"Yoon J.C.; Lim J.B.; Park J.H.; Lee J.M.; Cell-to-cell contact with hepatitis C virus-infected cells reduces functional capacity of natural killer cells. J Virol 2011,85(23),12557-12569","journal-title":"J Virol"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"5050","DOI":"10.1128\/JVI.03241-13","volume":"88","author":"Barretto N.","year":"2014","unstructured":"Barretto N.; Sainz B.; Hussain S.; Uprichard S.L.; Determining the involvement and therapeutic implications of host cellular factors in hepatitis C virus cell-to-cell spread. J Virol 2014,88(9),5050-5061","journal-title":"J Virol"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1126\/science.1114016","volume":"309","author":"Lindenbach B.D.","year":"2005","unstructured":"Lindenbach B.D.; Evans M.J.; Syder A.J.; Complete replication of hepatitis C virus in cell culture. Science 2005,309(5734),623-626","journal-title":"Science"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1038\/nm1268","volume":"11","author":"Wakita T.","year":"2005","unstructured":"Wakita T.; Pietschmann T.; Kato T.; Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat Med 2005,11(7),791-796","journal-title":"Nat Med"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"7034","DOI":"10.1128\/JVI.00118-08","volume":"82","author":"Steinmann E.","year":"2008","unstructured":"Steinmann E.; Brohm C.; Kallis S.; Bartenschlager R.; Pietschmann T.; Efficient trans-encapsidation of hepatitis C virus RNAs into infectious virus-like particles. J Virol 2008,82(14),7034-7046","journal-title":"J Virol"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.virol.2012.05.033","volume":"432","author":"Suzuki R.","year":"2012","unstructured":"Suzuki R.; Saito K.; Kato T.; Trans-complemented hepatitis C virus particles as a versatile tool for study of virus assembly and infection. Virology 2012,432(1),29-38","journal-title":"Virology"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/S1473-3099(14)70965-X","volume":"15","author":"Mina M.M.","year":"2015","unstructured":"Mina M.M.; Luciani F.; Cameron B.; Resistance to hepatitis C virus: potential genetic and immunological determinants. Lancet Infect Dis 2015,15(4),451-460","journal-title":"Lancet Infect Dis"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"3786","DOI":"10.3748\/wjg.v21.i13.3786","volume":"21","author":"Yang D.R.","year":"2015","unstructured":"Yang D.R.; Zhu H.Z.; Hepatitis C virus and antiviral innate immunity: who wins at tug-of-war? World J Gastroenterol 2015,21(13),3786-3800","journal-title":"World J Gastroenterol"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.antiviral.2013.09.020","volume":"100","author":"Baugh J.M.","year":"2013","unstructured":"Baugh J.M.; Garcia-Rivera J.A.; Gallay P.A.; Host-targeting agents in the treatment of hepatitis C: a beginning and an end? Antiviral Res 2013,100(2),555-561","journal-title":"Antiviral Res"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1016\/j.cmi.2016.08.025","volume":"22","author":"Dustin L.B.","year":"2016","unstructured":"Dustin L.B.; Bartolini B.; Capobianchi M.R.; Pistello M.; Hepatitis C virus: life cycle in cells, infection and host response, and analysis of molecular markers influencing the outcome of infection and response to therapy. Clin Microbiol Infect 2016,22(10),826-832","journal-title":"Clin Microbiol Infect"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1021\/acsinfecdis.6b00110","volume":"2","author":"Freedman H.","year":"2016","unstructured":"Freedman H.; Logan M.R.; Law J.L.; Houghton M.; Structure and Function of the Hepatitis C Virus Envelope Glycoproteins E1 and E2: Antiviral and Vaccine Targets. ACS Infect Dis 2016,2(11),749-762","journal-title":"ACS Infect Dis"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1126\/science.1243876","volume":"342","author":"Kong L.","year":"2013","unstructured":"Kong L.; Giang E.; Nieusma T.; Hepatitis C virus E2 envelope glycoprotein core structure. Science 2013,342(6162),1090-1094","journal-title":"Science"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/nature13117","volume":"509","author":"Khan A.G.","year":"2014","unstructured":"Khan A.G.; Whidby J.; Miller M.T.; Structure of the core ectodomain of the hepatitis C virus envelope glycoprotein 2. Nature 2014,509(7500),381-384","journal-title":"Nature"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/S0014-5793(03)00780-4","volume":"552","author":"Gonzalez M.E.","year":"2003","unstructured":"Gonzalez M.E.; Carrasco L.; Viroporins. FEBS Lett 2003,552(1),28-34","journal-title":"FEBS Lett"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"5063","DOI":"10.1128\/JVI.68.8.5063-5073.1994","volume":"68","author":"Lin C.","year":"1994","unstructured":"Lin C.; Lindenbach B.D.; Pr&#xE1;gai B.M.; McCourt D.W.; Rice C.M.; Processing in the hepatitis C virus E2-NS2 region: identification of p7 and two distinct E2-specific products with different C termini. J Virol 1994,68(8),5063-5073","journal-title":"J Virol"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"8374","DOI":"10.1128\/JVI.00690-07","volume":"81","author":"Jones C.T.","year":"2007","unstructured":"Jones C.T.; Murray C.L.; Eastman D.K.; Tassello J.; Rice C.M.; Hepatitis C virus p7 and NS2 proteins are essential for production of infectious virus. J Virol 2007,81(16),8374-8383","journal-title":"J Virol"},{"key":"ref=40","first-page":"962","volume":"3","author":"Steinmann E","year":"2007","unstructured":"Steinmann E; Penin F; Kallis S; Patel AH; Bartenschlager R; Pietschmann T;  Hepatitis C virus p7 protein is crucial for assembly and release of infectious virions PLoS Pathog 2007,3(7),962-71","journal-title":"Hepatitis C virus p7 protein is crucial for assembly and release of infectious virions PLoS Pathog"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"3720","DOI":"10.1128\/JVI.76.8.3720-3730.2002","volume":"76","author":"Carr&#xE8;re-Kremer S.","year":"2002","unstructured":"Carr&#xE8;re-Kremer S.; Montpellier-Pala C.; Cocquerel L.; Wychowski C.; Penin F.; Dubuisson J.; Subcellular localization and topology of the p7 polypeptide of hepatitis C virus. J Virol 2002,76(8),3720-3730","journal-title":"J Virol"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"37057","DOI":"10.1074\/jbc.M602434200","volume":"281","author":"Clarke D.","year":"2006","unstructured":"Clarke D.; Griffin S.; Beales L.; Evidence for the formation of a heptameric ion channel complex by the hepatitis C virus p7 protein in vitro. J Biol Chem 2006,281(48),37057-37068","journal-title":"J Biol Chem"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"12712","DOI":"10.1073\/pnas.0905966106","volume":"106","author":"Luik P.","year":"2009","unstructured":"Luik P.; Chew C.; Aittoniemi J.; The 3-dimensional structure of a hepatitis C virus p7 ion channel by electron microscopy. Proc Natl Acad Sci USA 2009,106(31),12712-12716","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"6104","DOI":"10.1073\/pnas.1031527100","volume":"100","author":"Pavlovi\u0107 D.","year":"2003","unstructured":"Pavlovi\u0107 D.; Neville D.C.; Argaud O.; The hepatitis C virus p7 protein forms an ion channel that is inhibited by long-alkyl-chain iminosugar derivatives. Proc Natl Acad Sci USA 2003,100(10),6104-6108","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"31446","DOI":"10.1074\/jbc.M110.122895","volume":"285","author":"Montserret R.","year":"2010","unstructured":"Montserret R.; Saint N.; Vanbelle C.; NMR structure and ion channel activity of the p7 protein from hepatitis C virus. J Biol Chem 2010,285(41),31446-31461","journal-title":"J Biol Chem"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"18256","DOI":"10.1074\/jbc.M209732200","volume":"278","author":"Erdtmann L.","year":"2003","unstructured":"Erdtmann L.; Franck N.; Lerat H.; The hepatitis C virus NS2 protein is an inhibitor of CIDE-B-induced apoptosis. J Biol Chem 2003,278(20),18256-18264","journal-title":"J Biol Chem"},{"key":"ref=47","first-page":"3","author":"Suarez D.L.","year":"2016","unstructured":"Suarez D.L.;  Influenza AVirusAnimal Influenza 2016,3","journal-title":"Influenza AVirusAnimal Influenza"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.3390\/v2081635","volume":"2","author":"Lorenz I.C.","year":"2010","unstructured":"Lorenz I.C.; The Hepatitis C Virus Nonstructural Protein 2 (NS2): An Up-and-Coming Antiviral Drug Target. Viruses 2010,2(8),1635-1646","journal-title":"Viruses"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"10583","DOI":"10.1073\/pnas.90.22.10583","volume":"90","author":"Grakoui A.","year":"1993","unstructured":"Grakoui A.; McCourt D.W.; Wychowski C.; Feinstone S.M.; Rice C.M.; A second hepatitis C virus-encoded proteinase. Proc Natl Acad Sci USA 1993,90(22),10583-10587","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"5342","DOI":"10.1073\/pnas.0810950106","volume":"106","author":"Schregel V.","year":"2009","unstructured":"Schregel V.; Jacobi S.; Penin F.; Tautz N.; Hepatitis C virus NS2 is a protease stimulated by cofactor domains in NS3. Proc Natl Acad Sci USA 2009,106(13),5342-5347","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"13001","DOI":"10.1128\/JVI.76.24.13001-13014.2002","volume":"76","author":"Blight K.J.","year":"2002","unstructured":"Blight K.J.; McKeating J.A.; Rice C.M.; Highly permissive cell lines for subgenomic and genomic hepatitis C virus RNA replication. J Virol 2002,76(24),13001-13014","journal-title":"J Virol"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1126\/science.285.5424.110","volume":"285","author":"Lohmann V.","year":"1999","unstructured":"Lohmann V.; K&#xF6;rner F.; Koch J.; Herian U.; Theilmann L.; Bartenschlager R.; Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line. Science 1999,285(5424),110-113","journal-title":"Science"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"29604","DOI":"10.1074\/jbc.M505019200","volume":"280","author":"Welbourn S.","year":"2005","unstructured":"Welbourn S.; Green R.; Gamache I.; Hepatitis C virus NS2\/3 processing is required for NS3 stability and viral RNA replication. J Biol Chem 2005,280(33),29604-29611","journal-title":"J Biol Chem"},{"key":"ref=54","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1001278","volume":"7","author":"Popescu C.I.","year":"2011","unstructured":"Popescu C.I.; Callens N.; Trinel D.; NS2 protein of hepatitis C virus interacts with structural and non-structural proteins towards virus assembly. PLoS Pathog 2011,7(2)","journal-title":"PLoS Pathog"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"28546","DOI":"10.1074\/jbc.M803981200","volume":"283","author":"Jirasko V.","year":"2008","unstructured":"Jirasko V.; Montserret R.; Appel N.; Structural and functional characterization of nonstructural protein 2 for its role in hepatitis C virus assembly. J Biol Chem 2008,283(42),28546-28562","journal-title":"J Biol Chem"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"7408","DOI":"10.1073\/pnas.0504877103","volume":"103","author":"Pietschmann T.","year":"2006","unstructured":"Pietschmann T.; Kaul A.; Koutsoudakis G.; Construction and characterization of infectious intragenotypic and intergenotypic hepatitis C virus chimeras. Proc Natl Acad Sci USA 2006,103(19),7408-7413","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=57","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1000403","volume":"5","author":"Yi M.","year":"2009","unstructured":"Yi M.; Ma Y.; Yates J.; Lemon S.M.; Trans-complementation of an NS2 defect in a late step in hepatitis C virus (HCV) particle assembly and maturation. PLoS Pathog 2009,5(5)","journal-title":"PLoS Pathog"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1038\/nature04975","volume":"442","author":"Lorenz I.C.","year":"2006","unstructured":"Lorenz I.C.; Marcotrigiano J.; Dentzer T.G.; Rice C.M.; Structure of the catalytic domain of the hepatitis C virus NS2-3 protease. Nature 2006,442(7104),831-835","journal-title":"Nature"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"e175","DOI":"10.1016\/j.ddtec.2011.11.002","volume":"9","author":"Weiser B.M.","year":"2012","unstructured":"Weiser B.M.; Tellinghuisen T.L.; Structural biology of the hepatitis C virus proteins. Drug Discov Today Technol 2012,9(3),e175-e226","journal-title":"Drug Discov Today Technol"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"10773","DOI":"10.1073\/pnas.90.22.10773","volume":"90","author":"Hijikata M.","year":"1993","unstructured":"Hijikata M.; Mizushima H.; Tanji Y.; Proteolytic processing and membrane association of putative nonstructural proteins of hepatitis C virus. Proc Natl Acad Sci USA 1993,90(22),10773-10777","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"22725","DOI":"10.1074\/jbc.R110.125294","volume":"285","author":"Raney K.D.","year":"2010","unstructured":"Raney K.D.; Sharma S.D.; Moustafa I.M.; Cameron C.E.; Hepatitis C.; Hepatitis C virus non-structural protein 3 (HCV NS3): a multifunctional antiviral target. J Biol Chem 2010,285(30),22725-22731","journal-title":"J Biol Chem"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"2074","DOI":"10.1021\/jm401432c","volume":"57","author":"LaPlante S.R.","year":"2014","unstructured":"LaPlante S.R.; Padyana A.K.; Abeywardane A.; Integrated strategies for identifying leads that target the NS3 helicase of the hepatitis C virus. J Med Chem 2014,57(5),2074-2090","journal-title":"J Med Chem"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"3268","DOI":"10.1128\/JVI.01849-08","volume":"83","author":"Beran R.K.","year":"2009","unstructured":"Beran R.K.; Lindenbach B.D.; Pyle A.M.; Pyle A.M.; The NS4A protein of hepatitis C virus promotes RNA-coupled ATP hydrolysis by the NS3 helicase. J Virol 2009,83(7),3268-3275","journal-title":"J Virol"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"3753","DOI":"10.1128\/JVI.68.6.3753-3760.1994","volume":"68","author":"Failla C.","year":"1994","unstructured":"Failla C.; Tomei L.; De Francesco R.; Both NS3 and NS4A are required for proteolytic processing of hepatitis C virus nonstructural proteins. J Virol 1994,68(6),3753-3760","journal-title":"J Virol"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1093\/emboj\/21.5.1168","volume":"21","author":"Pang P.S.","year":"2002","unstructured":"Pang P.S.; Jankowsky E.; Planet P.J.; Pyle A.M.; The hepatitis C viral NS3 protein is a processive DNA helicase with cofactor enhanced RNA unwinding. EMBO J 2002,21(5),1168-1176","journal-title":"EMBO J"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1128\/JVI.69.3.1575-1581.1995","volume":"69","author":"Tanji Y.","year":"1995","unstructured":"Tanji Y.; Hijikata M.; Satoh S.; Kaneko T.; Shimotohno K.; Hepatitis C virus-encoded nonstructural protein NS4A has versatile functions in viral protein processing. J Virol 1995,69(3),1575-1581","journal-title":"J Virol"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"2293","DOI":"10.1128\/JVI.74.5.2293-2304.2000","volume":"74","author":"W&#xF6;lk B.","year":"2000","unstructured":"W&#xF6;lk B.; Sansonno D.; Kr&#xE4;usslich H.G.; Subcellular localization, stability, and trans-cleavage competence of the hepatitis C virus NS3-NS4A complex expressed in tetracycline-regulated cell lines. J Virol 2000,74(5),2293-2304","journal-title":"J Virol"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"4479","DOI":"10.1021\/ol027014p","volume":"4","author":"Andrews D.M.","year":"2002","unstructured":"Andrews D.M.; Chaignot H.; Coomber B.A.; Pyrrolidine-5,5-trans-lactams. 2. The use of X-ray crystal structure data in the optimization of P3 and P4 substituents. Org Lett 2002,4(25),4479-4482","journal-title":"Org Lett"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"5045","DOI":"10.1128\/JVI.68.8.5045-5055.1994","volume":"68","author":"Bartenschlager R.","year":"1994","unstructured":"Bartenschlager R.; Ahlborn-Laake L.; Mous J.; Jacobsen H.; Kinetic and structural analyses of hepatitis C virus polyprotein processing. J Virol 1994,68(8),5045-5055","journal-title":"J Virol"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"7622","DOI":"10.1073\/pnas.92.17.7622","volume":"92","author":"Lin C.","year":"1995","unstructured":"Lin C.; Rice C.M.; The hepatitis C virus NS3 serine proteinase and NS4A cofactor: establishment of a cell-free trans-processing assay. Proc Natl Acad Sci USA 1995,92(17),7622-7626","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"7624","DOI":"10.1128\/JVI.00724-08","volume":"82","author":"Ma Y.","year":"2008","unstructured":"Ma Y.; Yates J.; Liang Y.; Lemon S.M.; Yi M.; NS3 helicase domains involved in infectious intracellular hepatitis C virus particle assembly. J Virol 2008,82(15),7624-7639","journal-title":"J Virol"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1016\/S0969-2126(00)80025-8","volume":"7","author":"Yao N.","year":"1999","unstructured":"Yao N.; Reichert P.; Taremi S.S.; Prosise W.W.; Weber P.C.; Molecular views of viral polyprotein processing revealed by the crystal structure of the hepatitis C virus bifunctional protease-helicase. Structure 1999,7(11),1353-1363","journal-title":"Structure"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1021\/jm400164c","volume":"57","author":"Jiang Y.","year":"2014","unstructured":"Jiang Y.; Andrews S.W.; Condroski K.R.; Discovery of danoprevir (ITMN-191\/R7227), a highly selective and potent inhibitor of hepatitis C virus (HCV) NS3\/4A protease. J Med Chem 2014,57(5),1753-1769","journal-title":"J Med Chem"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"4627","DOI":"10.1021\/ol035826v","volume":"5","author":"Slater M.J.","year":"2003","unstructured":"Slater M.J.; Amphlett E.M.; Andrews D.M.; Pyrrolidine-5,5-trans-lactams. 4. Incorporation of a P3\/P4 urea leads to potent intracellular inhibitors of hepatitis C virus NS3\/4A protease. Org Lett 2003,5(24),4627-4630","journal-title":"Org Lett"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"3835","DOI":"10.1128\/JVI.67.7.3835-3844.1993","volume":"67","author":"Bartenschlager R.","year":"1993","unstructured":"Bartenschlager R.; Ahlborn-Laake L.; Mous J.; Jacobsen H.; Nonstructural protein 3 of the hepatitis C virus encodes a serine-type proteinase required for cleavage at the NS3\/4 and NS4\/5 junctions. J Virol 1993,67(7),3835-3844","journal-title":"J Virol"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1128\/JVI.69.1.198-205.1995","volume":"69","author":"Bartenschlager R.","year":"1995","unstructured":"Bartenschlager R.; Ahlborn-Laake L.; Yasargil K.; Mous J.; Jacobsen H.; Substrate determinants for cleavage in cis and in trans by the hepatitis C virus NS3 proteinase. J Virol 1995,69(1),198-205","journal-title":"J Virol"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1128\/JVI.69.3.1769-1777.1995","volume":"69","author":"Failla C.","year":"1995","unstructured":"Failla C.; Tomei L.; De Francesco R.; An amino-terminal domain of the hepatitis C virus NS3 protease is essential for interaction with NS4A. J Virol 1995,69(3),1769-1777","journal-title":"J Virol"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"8147","DOI":"10.1128\/JVI.68.12.8147-8157.1994","volume":"68","author":"Lin C.","year":"1994","unstructured":"Lin C.; Pr&#xE1;gai B.M.; Grakoui A.; Xu J.; Rice C.M.; Hepatitis C virus NS3 serine proteinase: trans-cleavage requirements and processing kinetics. J Virol 1994,68(12),8147-8157","journal-title":"J Virol"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1002\/hep.20032","volume":"39","author":"Penin F.","year":"2004","unstructured":"Penin F.; Dubuisson J.; Rey F.A.; Moradpour D.; Pawlotsky J.M.; Structural biology of hepatitis C virus. Hepatology 2004,39(1),5-19","journal-title":"Hepatology"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0166-3542(03)00028-7","volume":"58","author":"De Francesco R.","year":"2003","unstructured":"De Francesco R.; Tomei L.; Altamura S.; Summa V.; Migliaccio G.; Approaching a new era for hepatitis C virus therapy: inhibitors of the NS3-4A serine protease and the NS5B RNA-dependent RNA polymerase. Antiviral Res 2003,58(1),1-16","journal-title":"Antiviral Res"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/S0092-8674(00)81350-1","volume":"87","author":"Love R.A.","year":"1996","unstructured":"Love R.A.; Parge H.E.; Wickersham J.A.; The crystal structure of hepatitis C virus NS3 proteinase reveals a trypsin-like fold and a structural zinc binding site. Cell 1996,87(2),331-342","journal-title":"Cell"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"2881","DOI":"10.1128\/JVI.71.4.2881-2886.1997","volume":"71","author":"Stempniak M.","year":"1997","unstructured":"Stempniak M.; Hostomska Z.; Nodes B.R.; Hostomsky Z.; The NS3 proteinase domain of hepatitis C virus is a zinc-containing enzyme. J Virol 1997,71(4),2881-2886","journal-title":"J Virol"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"2992","DOI":"10.1073\/pnas.0408824102","volume":"102","author":"Li K.","year":"2005","unstructured":"Li K.; Foy E.; Ferreon J.C.; Jr.Gale, M.; Lemon, S.M. Immune evasions by hepatitis C virus NS3\/4A protease mediate cleavage of the Toll-like receptor 3 adaptor protein TRIF. Proc Natl Acad Sci USA 2005,102(8),2992-2997","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1038\/nature04193","volume":"437","author":"Meylan E.","year":"2005","unstructured":"Meylan E.; Curran J.; Hofmann K.; Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus. Nature 2005,437(7062),1167-1172","journal-title":"Nature"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"15045","DOI":"10.1074\/jbc.273.24.15045","volume":"273","author":"Cho H.S.","year":"1998","unstructured":"Cho H.S.; Ha N.C.; Kang L.W.; Crystal structure of RNA helicase from genotype 1b hepatitis C virus. A feasible mechanism of unwinding duplex RNA. J Biol Chem 1998,273(24),15045-15052","journal-title":"J Biol Chem"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/S0969-2126(98)00010-0","volume":"6","author":"Kim J.L.","year":"1998","unstructured":"Kim J.L.; Morgenstern K.A.; Griffith J.P.; Hepatitis C virus NS3 RNA helicase domain with a bound oligonucleotide: the crystal structure provides insights into the mode of unwinding. Structure 1998,6(1),89-100","journal-title":"Structure"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/nsb0697-463","volume":"4","author":"Yao N.","year":"1997","unstructured":"Yao N.; Hesson T.; Cable M.; Structure of the hepatitis C virus RNA helicase domain. Nat Struct Biol 1997,4(6),463-467","journal-title":"Nat Struct Biol"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"6106","DOI":"10.1128\/JVI.00377-11","volume":"85","author":"Romano K.P.","year":"2011","unstructured":"Romano K.P.; Laine J.M.; Deveau L.M.; Cao H.; Massi F.; Schiffer C.A.; Molecular mechanisms of viral and host cell substrate recognition by hepatitis C virus NS3\/4A protease. J Virol 2011,85(13),6106-6116","journal-title":"J Virol"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/nature04331","volume":"439","author":"Dumont S.","year":"2006","unstructured":"Dumont S.; Cheng W.; Serebrov V.; RNA translocation and unwinding mechanism of HCV NS3 helicase and its coordination by ATP. Nature 2006,439(7072),105-108","journal-title":"Nature"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1038\/nsmb920","volume":"12","author":"Levin M.K.","year":"2005","unstructured":"Levin M.K.; Gurjar M.; Patel S.S.; A Brownian motor mechanism of translocation and strand separation by hepatitis C virus helicase. Nat Struct Mol Biol 2005,12(5),429-435","journal-title":"Nat Struct Mol Biol"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"26005","DOI":"10.1074\/jbc.M403257200","volume":"279","author":"Levin M.K.","year":"2004","unstructured":"Levin M.K.; Wang Y.H.; Patel S.S.; The functional interaction of the hepatitis C virus helicase molecules is responsible for unwinding processivity. J Biol Chem 2004,279(25),26005-26012","journal-title":"J Biol Chem"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1038\/nature02704","volume":"430","author":"Serebrov V.","year":"2004","unstructured":"Serebrov V.; Pyle A.M.; Periodic cycles of RNA unwinding and pausing by hepatitis C virus NS3 helicase. Nature 2004,430(6998),476-480","journal-title":"Nature"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"10332","DOI":"10.1021\/bi026082g","volume":"41","author":"Locatelli G.A.","year":"2002","unstructured":"Locatelli G.A.; Spadari S.; Maga G.; Hepatitis C virus NS3 ATPase\/helicase: an ATP switch regulates the cooperativity among the different substrate binding sites. Biochemistry 2002,41(32),10332-10342","journal-title":"Biochemistry"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"3528","DOI":"10.1074\/jbc.M512100200","volume":"281","author":"Mackintosh S.G.","year":"2006","unstructured":"Mackintosh S.G.; Lu J.Z.; Jordan J.B.; Structural and biological identification of residues on the surface of NS3 helicase required for optimal replication of the hepatitis C virus. J Biol Chem 2006,281(6),3528-3535","journal-title":"J Biol Chem"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1038\/nrd1853","volume":"4","author":"Kwong A.D.","year":"2005","unstructured":"Kwong A.D.; Rao B.G.; Jeang K.T.; Viral and cellular RNA helicases as antiviral targets. Nat Rev Drug Discov 2005,4(10),845-853","journal-title":"Nat Rev Drug Discov"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"3002","DOI":"10.1128\/JCM.36.10.3002-3006.1998","volume":"36","author":"Beld M.","year":"1998","unstructured":"Beld M.; Penning M.; van Putten M.; Hepatitis C virus serotype-specific core and NS4 antibodies in injecting drug users participating in the Amsterdam cohort studies. J Clin Microbiol 1998,36(10),3002-3006","journal-title":"J Clin Microbiol"},{"key":"ref=97","author":"Sklan E.H.","year":"2006","unstructured":"Sklan E.H.; Glenn J.S.;  Chapter8 HCV NS4B: From Obscurity to Central Stage in Hepatitis C Viruses: Genomes and Molecular Biology Tan SL 2006","journal-title":"Chapter8 HCV NS4B: From Obscurity to Central Stage in Hepatitis C Viruses: Genomes and Molecular Biology Tan SL"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"5974","DOI":"10.1128\/JVI.76.12.5974-5984.2002","volume":"76","author":"Egger D.","year":"2002","unstructured":"Egger D.; W&#xF6;lk B.; Gosert R.; Expression of hepatitis C virus proteins induces distinct membrane alterations including a candidate viral replication complex. J Virol 2002,76(12),5974-5984","journal-title":"J Virol"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"3263","DOI":"10.1099\/vir.0.82211-0","volume":"87","author":"Lundin M.","year":"2006","unstructured":"Lundin M.; Lindstr&#xF6;m H.; Gr&#xF6;nwall C.; Persson M.A.; Dual topology of the processed hepatitis C virus protein NS4B is influenced by the NS5A protein. J Gen Virol 2006,87(Pt 11),3263-3272","journal-title":"J Gen Virol"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"6257","DOI":"10.1128\/JVI.02663-08","volume":"83","author":"Gouttenoire J.","year":"2009","unstructured":"Gouttenoire J.; Castet V.; Montserret R.; Identification of a novel determinant for membrane association in hepatitis C virus nonstructural protein 4B. J Virol 2009,83(12),6257-6268","journal-title":"J Virol"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"11288","DOI":"10.1128\/JVI.78.20.11288-11295.2004","volume":"78","author":"Einav S.","year":"2004","unstructured":"Einav S.; Elazar M.; Danieli T.; Glenn J.S.; A nucleotide binding motif in hepatitis C virus (HCV) NS4B mediates HCV RNA replication. J Virol 2004,78(20),11288-11295","journal-title":"J Virol"},{"key":"ref=102","doi-asserted-by":"publisher","first-page":"11378","DOI":"10.1128\/JVI.01122-09","volume":"83","author":"Gouttenoire J.","year":"2009","unstructured":"Gouttenoire J.; Montserret R.; Kennel A.; Penin F.; Moradpour D.; An amphipathic alpha-helix at the C terminus of hepatitis C virus nonstructural protein 4B mediates membrane association. J Virol 2009,83(21),11378-11384","journal-title":"J Virol"},{"key":"ref=103","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.virusres.2012.09.007","volume":"170","author":"Belda O.","year":"2012","unstructured":"Belda O.; Targett-Adams P.; Small molecule inhibitors of the hepatitis C virus-encoded NS5A protein. Virus Res 2012,170(1-2),1-14","journal-title":"Virus Res"},{"key":"ref=104","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.virol.2007.01.042","volume":"364","author":"Huang Y.","year":"2007","unstructured":"Huang Y.; Staschke K.; De Francesco R.; Tan S.L.; Phosphorylation of hepatitis C virus NS5A nonstructural protein: a new paradigm for phosphorylation-dependent viral RNA replication? Virology 2007,364(1),1-9","journal-title":"Virology"},{"key":"ref=105","doi-asserted-by":"publisher","first-page":"2485","DOI":"10.1099\/vir.0.80204-0","volume":"85","author":"Macdonald A.","year":"2004","unstructured":"Macdonald A.; Harris M.; Hepatitis C virus NS5A: tales of a promiscuous protein. J Gen Virol 2004,85(Pt 9),2485-2502","journal-title":"J Gen Virol"},{"key":"ref=106","author":"He Y.","year":"2006","unstructured":"He Y.; Staschke K.A.; Tan S.L.;  HCV NS5A: A multifunctional Regulator of Cellular Pathways and Virus ReplicationHepatitis C Viruses: Genomes and Molecular Biology 2006","journal-title":"HCV NS5A: A multifunctional Regulator of Cellular Pathways and Virus ReplicationHepatitis C Viruses: Genomes and Molecular Biology"},{"key":"ref=107","doi-asserted-by":"publisher","first-page":"48576","DOI":"10.1074\/jbc.M407787200","volume":"279","author":"Tellinghuisen T.L.","year":"2004","unstructured":"Tellinghuisen T.L.; Marcotrigiano J.; Gorbalenya A.E.; Rice C.M.; The NS5A protein of hepatitis C virus is a zinc metalloprotein. J Biol Chem 2004,279(47),48576-48587","journal-title":"J Biol Chem"},{"key":"ref=108","doi-asserted-by":"publisher","first-page":"9267","DOI":"10.1128\/JVI.00616-10","volume":"84","author":"Foster T.L.","year":"2010","unstructured":"Foster T.L.; Belyaeva T.; Stonehouse N.J.; Pearson A.R.; Harris M.; All three domains of the hepatitis C virus nonstructural NS5A protein contribute to RNA binding. J Virol 2010,84(18),9267-9277","journal-title":"J Virol"},{"key":"ref=109","doi-asserted-by":"publisher","first-page":"36417","DOI":"10.1074\/jbc.M508175200","volume":"280","author":"Huang L.","year":"2005","unstructured":"Huang L.; Hwang J.; Sharma S.D.; Hepatitis C virus nonstructural protein 5A (NS5A) is an RNA-binding protein. J Biol Chem 2005,280(43),36417-36428","journal-title":"J Biol Chem"},{"key":"ref=110","doi-asserted-by":"publisher","first-page":"4395","DOI":"10.1128\/JVI.02352-08","volume":"83","author":"Love R.A.","year":"2009","unstructured":"Love R.A.; Brodsky O.; Hickey M.J.; Wells P.A.; Cronin C.N.; Crystal structure of a novel dimeric form of NS5A domain I protein from hepatitis C virus. J Virol 2009,83(9),4395-4403","journal-title":"J Virol"},{"key":"ref=111","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1038\/nature03580","volume":"435","author":"Tellinghuisen T.L.","year":"2005","unstructured":"Tellinghuisen T.L.; Marcotrigiano J.; Rice C.M.; Structure of the zinc-binding domain of an essential component of the hepatitis C virus replicase. Nature 2005,435(7040),374-379","journal-title":"Nature"},{"key":"ref=112","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1126\/science.290.5498.1972","volume":"290","author":"Blight K.J.","year":"2000","unstructured":"Blight K.J.; Kolykhalov A.A.; Rice C.M.; Efficient initiation of HCV RNA replication in cell culture. Science 2000,290(5498),1972-1974","journal-title":"Science"},{"key":"ref=113","doi-asserted-by":"publisher","first-page":"2046","DOI":"10.1128\/JVI.74.4.2046-2051.2000","volume":"74","author":"Kolykhalov A.A.","year":"2000","unstructured":"Kolykhalov A.A.; Mihalik K.; Feinstone S.M.; Rice C.M.; Hepatitis C virus-encoded enzymatic activities and conserved RNA elements in the 3\u2032 nontranslated region are essential for virus replication in vivo. J Virol 2000,74(4),2046-2051","journal-title":"J Virol"},{"key":"ref=114","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1007\/s00018-002-8478-7","volume":"59","author":"L&#xE9;v&#xEA;que V.J.","year":"2002","unstructured":"L&#xE9;v&#xEA;que V.J.; Wang Q.M.; RNA-dependent RNA polymerase encoded by hepatitis C virus: biomedical applications. Cell Mol Life Sci 2002,59(6),909-919","journal-title":"Cell Mol Life Sci"},{"key":"ref=115","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1128\/CVI.00287-08","volume":"16","author":"Gehring S.","year":"2009","unstructured":"Gehring S.; Gregory S.H.; Wintermeyer P.; Aloman C.; Wands J.R.; Generation of immune responses against hepatitis C virus by dendritic cells containing NS5 protein-coated microparticles. Clin Vaccine Immunol 2009,16(2),163-171","journal-title":"Clin Vaccine Immunol"},{"key":"ref=116","doi-asserted-by":"publisher","first-page":"13278","DOI":"10.1128\/JVI.78.23.13278-13284.2004","volume":"78","author":"Moradpour D.","year":"2004","unstructured":"Moradpour D.; Brass V.; Bieck E.; Membrane association of the RNA-dependent RNA polymerase is essential for hepatitis C virus RNA replication. J Virol 2004,78(23),13278-13284","journal-title":"J Virol"},{"key":"ref=117","doi-asserted-by":"publisher","first-page":"44052","DOI":"10.1074\/jbc.M103358200","volume":"276","author":"Schmidt-Mende J.","year":"2001","unstructured":"Schmidt-Mende J.; Bieck E.; Hugle T.; Determinants for membrane association of the hepatitis C virus RNA-dependent RNA polymerase. J Biol Chem 2001,276(47),44052-44063","journal-title":"J Biol Chem"},{"key":"ref=118","doi-asserted-by":"publisher","first-page":"13088","DOI":"10.1128\/JVI.76.24.13088-13093.2002","volume":"76","author":"Ivashkina N.","year":"2002","unstructured":"Ivashkina N.; W&#xF6;lk B.; Lohmann V.; The hepatitis C virus RNA-dependent RNA polymerase membrane insertion sequence is a transmembrane segment. J Virol 2002,76(24),13088-13093","journal-title":"J Virol"},{"key":"ref=119","doi-asserted-by":"publisher","first-page":"10674","DOI":"10.1074\/jbc.M111.325530","volume":"287","author":"Jin Z.","year":"2012","unstructured":"Jin Z.; Leveque V.; Ma H.; Johnson K.A.; Klumpp K.; Assembly, purification, and pre-steady-state kinetic analysis of active RNA-dependent RNA polymerase elongation complex. J Biol Chem 2012,287(13),10674-10683","journal-title":"J Biol Chem"},{"key":"ref=120","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nrmicro1645","volume":"5","author":"Moradpour D.","year":"2007","unstructured":"Moradpour D.; Penin F.; Rice C.M.; Replication of hepatitis C virus. Nat Rev Microbiol 2007,5(6),453-463","journal-title":"Nat Rev Microbiol"},{"key":"ref=121","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.antiviral.2010.08.014","volume":"88","author":"Rigat K.","year":"2010","unstructured":"Rigat K.; Wang Y.; Hudyma T.W.; Ligand-induced changes in hepatitis C virus NS5B polymerase structure. Antiviral Res 2010,88(2),197-206","journal-title":"Antiviral Res"},{"key":"ref=122","doi-asserted-by":"publisher","first-page":"18202","DOI":"10.1074\/jbc.M413410200","volume":"280","author":"Biswal B.K.","year":"2005","unstructured":"Biswal B.K.; Cherney M.M.; Wang M.; Crystal structures of the RNA-dependent RNA polymerase genotype 2a of hepatitis C virus reveal two conformations and suggest mechanisms of inhibition by non-nucleoside inhibitors. J Biol Chem 2005,280(18),18202-18210","journal-title":"J Biol Chem"},{"key":"ref=123","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1016\/S0022-2836(02)01439-0","volume":"326","author":"O\u2019Farrell D.","year":"2003","unstructured":"O\u2019Farrell D.; Trowbridge R.; Rowlands D.; J&#xE4;ger J.; Substrate complexes of hepatitis C virus RNA polymerase (HC-J4): structural evidence for nucleotide import and de-novo initiation. J Mol Biol 2003,326(4),1025-1035","journal-title":"J Mol Biol"},{"key":"ref=124","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1016\/S0969-2126(00)80031-3","volume":"7","author":"Ago H.","year":"1999","unstructured":"Ago H.; Adachi T.; Yoshida A.; Crystal structure of the RNA-dependent RNA polymerase of hepatitis C virus. Structure 1999,7(11),1417-1426","journal-title":"Structure"},{"key":"ref=125","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1038\/13305","volume":"6","author":"Lesburg C.A.","year":"1999","unstructured":"Lesburg C.A.; Cable M.B.; Ferrari E.; Hong Z.; Mannarino A.F.; Weber P.C.; Crystal structure of the RNA-dependent RNA polymerase from hepatitis C virus reveals a fully encircled active site. Nat Struct Biol 1999,6(10),937-943","journal-title":"Nat Struct Biol"},{"key":"ref=126","doi-asserted-by":"publisher","first-page":"13034","DOI":"10.1073\/pnas.96.23.13034","volume":"96","author":"Bressanelli S.","year":"1999","unstructured":"Bressanelli S.; Tomei L.; Roussel A.; Crystal structure of the RNA-dependent RNA polymerase of hepatitis C virus. Proc Natl Acad Sci USA 1999,96(23),13034-13039","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=127","doi-asserted-by":"publisher","first-page":"3482","DOI":"10.1128\/JVI.76.7.3482-3492.2002","volume":"76","author":"Bressanelli S.","year":"2002","unstructured":"Bressanelli S.; Tomei L.; Rey F.A.; De Francesco R.; Structural analysis of the hepatitis C virus RNA polymerase in complex with ribonucleotides. J Virol 2002,76(7),3482-3492","journal-title":"J Virol"},{"key":"ref=128","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1006\/viro.2001.0948","volume":"285","author":"Hong Z.","year":"2001","unstructured":"Hong Z.; Cameron C.E.; Walker M.P.; A novel mechanism to ensure terminal initiation by hepatitis C virus NS5B polymerase. Virology 2001,285(1),6-11","journal-title":"Virology"},{"key":"ref=129","doi-asserted-by":"publisher","first-page":"38011","DOI":"10.1074\/jbc.M508145200","volume":"280","author":"Kim Y.C.","year":"2005","unstructured":"Kim Y.C.; Russell W.K.; Ranjith-Kumar C.T.; Thomson M.; Russell D.H.; Kao C.C.; Functional analysis of RNA binding by the hepatitis C virus RNA-dependent RNA polymerase. J Biol Chem 2005,280(45),38011-38019","journal-title":"J Biol Chem"},{"key":"ref=130","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/S0022-2836(03)00613-2","volume":"330","author":"Ranjith-Kumar C.T.","year":"2003","unstructured":"Ranjith-Kumar C.T.; Gutshall L.; Sarisky R.T.; Kao C.C.; Multiple interactions within the hepatitis C virus RNA polymerase repress primer-dependent RNA synthesis. J Mol Biol 2003,330(4),675-685","journal-title":"J Mol Biol"},{"key":"ref=131","doi-asserted-by":"publisher","first-page":"11607","DOI":"10.1128\/JVI.79.18.11607-11617.2005","volume":"79","author":"Cai Z.","year":"2005","unstructured":"Cai Z.; Yi M.; Zhang C.; Luo G.; Mutagenesis analysis of the rGTP-specific binding site of hepatitis C virus RNA-dependent RNA polymerase. J Virol 2005,79(18),11607-11617","journal-title":"J Virol"},{"key":"ref=132","doi-asserted-by":"publisher","first-page":"9020","DOI":"10.1128\/JVI.77.16.9020-9028.2003","volume":"77","author":"L&#xE9;v&#xEA;que V.J.","year":"2003","unstructured":"L&#xE9;v&#xEA;que V.J.; Johnson R.B.; Parsons S.; Identification of a C-terminal regulatory motif in hepatitis C virus RNA-dependent RNA polymerase: structural and biochemical analysis. J Virol 2003,77(16),9020-9028","journal-title":"J Virol"},{"key":"ref=133","doi-asserted-by":"publisher","first-page":"3865","DOI":"10.1128\/JVI.76.8.3865-3872.2002","volume":"76","author":"Wang Q.M.","year":"2002","unstructured":"Wang Q.M.; Hockman M.A.; Staschke K.; Oligomerization and cooperative RNA synthesis activity of hepatitis C virus RNA-dependent RNA polymerase. J Virol 2002,76(8),3865-3872","journal-title":"J Virol"},{"key":"ref=134","doi-asserted-by":"publisher","first-page":"45670","DOI":"10.1074\/jbc.M204124200","volume":"277","author":"Piccininni S.","year":"2002","unstructured":"Piccininni S.; Varaklioti A.; Nardelli M.; Dave B.; Raney K.D.; McCarthy J.E.; Modulation of the hepatitis C virus RNA-dependent RNA polymerase activity by the non-structural (NS) 3 helicase and the NS4B membrane protein. J Biol Chem 2002,277(47),45670-45679","journal-title":"J Biol Chem"},{"key":"ref=135","doi-asserted-by":"publisher","author":"Shirota Y","unstructured":"Shirota Y; Luo H; Qin W;  Hepatitis C virus (HCV) NS5A binds RNA-dependent RNA polymerase (RdRP) NS5B and modulates RNA-dependent RNA polymerase activity. J Biol Chem 2002; 277(13): 11149-55.","DOI":"10.1074\/jbc.M111392200"}],"container-title":["Current Drug Targets"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download\/184200","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/184200\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download\/184200","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,26]],"date-time":"2022-02-26T20:00:02Z","timestamp":1645905602000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/184200\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":135,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1389450121999200727215020","relation":{},"ISSN":["1389-4501"],"issn-type":[{"value":"1389-4501","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2020-03-06","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-05-05","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-05-11","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-04-08","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}